Plant KE et al. |
Intergenic transcription in the human beta-globin gene cluster. |
2001 |
Mol. Cell. Biol. |
pmid:11533239
|
Chen Lf W et al. |
Duration of nuclear NF-kappaB action regulated by reversible acetylation. |
2001 |
Science |
pmid:11533489
|
Vinatzer U et al. |
The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase. |
2001 |
Br. J. Haematol. |
pmid:11552981
|
Sekimata M et al. |
Involvement of a novel zinc finger protein, MIZF, in transcriptional repression by interacting with a methyl-CpG-binding protein, MBD2. |
2001 |
J. Biol. Chem. |
pmid:11553631
|
Deltour S et al. |
Characterization of HRG22, a human homologue of the putative tumor suppressor gene HIC1. |
2001 |
Biochem. Biophys. Res. Commun. |
pmid:11554746
|
Kim MS et al. |
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes. |
2001 |
Nat. Med. |
pmid:11283670
|
Vigushin DM et al. |
Trichostatin A is a histone deacetylase inhibitor with potent antitumor activity against breast cancer in vivo. |
2001 |
Clin. Cancer Res. |
pmid:11309348
|
Magdinier F and Wolffe AP |
Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia. |
2001 |
Proc. Natl. Acad. Sci. U.S.A. |
pmid:11309512
|
Grande A et al. |
A functionally active RARalpha nuclear receptor is expressed in retinoic acid non responsive early myeloblastic cell lines. |
2001 |
Cell Death Differ. |
pmid:11313705
|
Wu Y et al. |
Negative regulation of bcl-2 expression by p53 in hematopoietic cells. |
2001 |
Oncogene |
pmid:11313951
|
Greenberg VL et al. |
Histone deacetylase inhibitors promote apoptosis and differential cell cycle arrest in anaplastic thyroid cancer cells. |
2001 |
Thyroid |
pmid:11349829
|
Lea MA et al. |
Induction of histone acetylation in mouse erythroleukemia cells by some organosulfur compounds including allyl isothiocyanate. |
2001 |
Int. J. Cancer |
pmid:11351296
|
Jordan A et al. |
The site of HIV-1 integration in the human genome determines basal transcriptional activity and response to Tat transactivation. |
2001 |
EMBO J. |
pmid:11285236
|
Arthur JL et al. |
Herpes simplex virus type 1 promoter activity during latency establishment, maintenance, and reactivation in primary dorsal root neurons in vitro. |
2001 |
J. Virol. |
pmid:11264377
|
Muth V et al. |
Acetylation of TAF(I)68, a subunit of TIF-IB/SL1, activates RNA polymerase I transcription. |
2001 |
EMBO J. |
pmid:11250901
|
Laribee RN and Klemsz MJ |
Loss of PU.1 expression following inhibition of histone deacetylases. |
2001 |
J. Immunol. |
pmid:11673528
|
Biade S et al. |
Chemical agents that promote chromatin compaction radiosensitize tumour cells. |
2001 |
Int. J. Radiat. Biol. |
pmid:11682008
|
Mishra SK et al. |
Dynamic chromatin remodeling on the HER2 promoter in human breast cancer cells. |
2001 |
FEBS Lett. |
pmid:11682064
|
Sharma M and Sun Z |
5'TG3' interacting factor interacts with Sin3A and represses AR-mediated transcription. |
2001 |
Mol. Endocrinol. |
pmid:11682623
|
Lavoie R et al. |
Design and synthesis of a novel class of histone deacetylase inhibitors. |
2001 |
Bioorg. Med. Chem. Lett. |
pmid:11597413
|